27th May 2021

Case against Italian mountain bike champion postponed to 4 June

Italy’s national anti-doping tribunal (TNA) will hear a case alleging that Elena Gaddoni is guilty of an anti-doping rule violation (ADRV) involving acetazolamide on 4 June. The Italian mountain bike marathon champion has been provisionally suspended since 15 February, when she returned an adverse analytical finding (AAF) for the diuretic at an out of competition test.

New WADA guidance sets a 20ng/mL limit for acetazolamide…

The case against Gaddoni was due to be heard this month, but Italy’s national anti-doping agency (NADO Italia) announced it had been postponed until 4 June. It could be complicated by new guidance from the World Anti-Doping Agency (WADA), which recognises that AAFs for acetazolamide can be caused by contaminated pharmaceutical products. This outlines that Laboratory findings indicating the presence of acetazolamide in urine at a concentration lower than 20ng/mL should be reported as a negative finding and not an AAF (see right). 

NADO Italia hasn’t announced the concentration of acetazolamide detected in Gaddoni’s urine and as such, it remains unclear as to whether WADA’s new guidelines will apply. The new guidance was published on 20 May but doesn’t come into force until 1 June.

You may also like...

Pin It on Pinterest

Share This